Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Platform revision updated from v3.4.2 to v3.4.3; no changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-06T17:44:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.
    Difference
    0.1%
    Check dated 2026-02-13T07:47:33.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T13:34:01.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The glossary is now displayed, QC-related labels have been updated (Last Update Submitted that Met QC Criteria) with the footer text showing No FEAR Act Data, and the site revision is now Revision: v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T06:45:51.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added, replacing the previous v3.3.3. This is a minor site maintenance update and does not affect study details or other visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:55:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section listing California, Illinois, and Pennsylvania. Removed the separate California Locations, Illinois Locations, and Pennsylvania Locations entries.
    Difference
    0.4%
    Check dated 2025-12-23T17:29:31.000Z thumbnail image

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.